Peptides · Peptide comparison
Epithalon vs Livagen
A tiny but mighty four-amino-acid peptide that activates your body's telomerase enzyme—essentially helping your cells hit the 'reset' button on aging by protecting and lengthening the protective caps on your chromosomes [1][2].
Tetrapeptide bioregulator (Lys-Glu-Asp-Ala) that directly penetrates cell nuclei and binds double-stranded DNA to induce chromatin decondensation in senescent lymphocytes, activate ribosomal genes, inhibit enkephalin-degrading enzymes with an IC50 of 20 μM, and restore protein synthesis capacity in aging cells through selective epigenetic remodeling
- Anti-Aging
- Anti-Aging
At a glance
Quick comparison
Efficacy
Benefit ratings
Telomere Protection
Sleep Quality
Cellular Longevity
Cell Renewal
Liver Support
DNA Protection
Technical data
Compound specifications
Epithalon
- Molecular formula
- C14H22N4O9
- Molecular weight
- 390.35 g/mol
- Half-life
- 2-4 hours (estimated)
- Bioavailability
- High when injected subcutaneously
- CAS number
- 307297-39-8
Livagen
- Molecular formula
- C18H31N5O9
- Molecular weight
- 461.5 g/mol
- Half-life
- Short plasma half-life typical of tetrapeptides; biological effects persist for weeks through epigenetic chromatin remodeling modifications; metabolized to constituent amino acids (lysine, glutamic acid, aspartic acid, alanine)
- Bioavailability
- Resistant to intestinal proteolysis when administered orally (weakly hydrolyzed by intestinal peptidases); efficient absorption from intramuscular injection sites; penetrates cytoplasmic and nuclear membranes to reach cell nuclei and nucleoli
- CAS number
- Not assigned (research compound)
Protocols
Dosing compared
Epithalon
Sublingual or parabulbar
- 0.5 mg (sublingual) / 5.0 micrograms per eye (parabulbar)Once daily · 20 days (sublingual) or 10 days (parabulbar)Source class: clinical trial protocol. These are the only two human uses of the synthetic tetrapeptide Epitalon identified in a 2025 peer-reviewed review: 5.0 micrograms per eye injected parabulbarly for 10 consecutive days in retinitis pigmentosa, and 0.5 mg per day sublingually for 20 days in a circadian rhythm study [3]. The same review states that toxicity studies needed before approval as an active ingredient have not been done [3].
Subcutaneous
- 5-10 mgOnce daily · 10-20 day course, repeated 1-3 times per yearSource class: community practice, not peer-reviewed. No published human study has given the synthetic tetrapeptide Epitalon by subcutaneous or intramuscular injection at any dose. This figure is 10 to 20 times the only systemic human dose reported for the synthetic peptide, which is 0.5 mg per day sublingually [3]. It is often attributed to Khavinson's Russian clinical work, but that work used Epithalamin, the pineal gland extract, rather than the synthetic peptide [6][8].
Livagen
Intramuscular
- 5-10 mgOnce daily · 10-day course (50-100 mg total)Reflects the Khavinson-laboratory bioregulator course used in practice: a total of 50-100 mg of the KEDA tetrapeptide delivered over 10 days. Livagen has no standardized human clinical dosing; evidence is largely preclinical [6].
Applications
Best suited for
Epithalon
- Longevity Enthusiasts
- If you're serious about healthy aging and want to support your cells at the deepest level, Epithalon targets one of the fundamental mechanisms of cellular aging—telomere shortening [1][2]. It's like giving your cells' protective caps a little extra reinforcement.
- Sleep Quality Seekers
- Epithalon helps regulate melatonin production by supporting your pineal gland [3]. Many users report better sleep quality and more consistent sleep-wake cycles, especially those who've noticed their sleep getting worse with age.
- Those Concerned About Oxidative Stress
- Beyond its telomere effects, Epithalon acts as an antioxidant [5]. If you're exposed to environmental stressors, have a demanding lifestyle, or simply want extra cellular protection, this peptide offers multiple mechanisms of support.
- Immune System Support (Age-Related)
- As we age, our immune system naturally weakens—a process called immunosenescence. Research suggests Epithalon may help maintain immune function by supporting the thymus and immune cell health, potentially keeping your defenses stronger as you age [7].
Livagen
- Comprehensive geroprotective therapy targeting epigenetic chromatin remodeling in aging cells
- Livagen is particularly well-suited for individuals focused on comprehensive geroprotective therapy targeting epigenetic chromatin remodeling in aging cells. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Supporting liver function and hepatoprotection in the context of aging
- Livagen is particularly well-suited for individuals focused on supporting liver function and hepatoprotection in the context of aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Restoring protein synthesis and ribosomal function in elderly individuals
- Livagen is particularly well-suited for individuals focused on restoring protein synthesis and ribosomal function in elderly individuals. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Khavinson bioregulator protocols for anti-aging and longevity
- Livagen is particularly well-suited for individuals focused on khavinson bioregulator protocols for anti-aging and longevity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Epithalon
Common
- Injection site redness
- Mild headache
- Temporary fatigue
Uncommon
- Vivid dreams
- Sleep pattern changes
Serious
- Allergic reaction
Livagen
Common
- Injection site reaction
- Mild fatigue
- Mild headache
- Digestive enzyme changes
Uncommon
- Transient flu-like symptoms
Serious
- No documented serious adverse effects
Research status
Safety & evidence
Epithalon
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Two different substances share this page's name, and almost all of the human data belongs to the older one. Epithalamin is an extract of the pineal gland. Epitalon (also written Epithalon, sequence Ala-Glu-Asp-Gly) is the synthetic four-amino-acid peptide later identified within it [4]. The long-term human studies people cite for this compound used **Epithalamin, the extract** — not the synthetic peptide. Those studies report the outcomes plainly. In 266 elderly people followed 6-8 years, mortality in the Epithalamin group fell 1.6-1.8-fold against control [6]. In a separate 12-year randomised study in elderly patients with coronary disease, deaths in the epithalamine group were 28% lower than control on the same basic therapy, and cardiovascular mortality was 2-fold lower [8]. For the synthetic peptide itself, a 2025 peer-reviewed review identifies only two human uses: 5.0 micrograms per eye injected parabulbarly for 10 consecutive days in retinitis pigmentosa, and 0.5 mg per day sublingually for 20 days in a circadian rhythm study [3]. That same review states that before Epitalon could be approved as a new active ingredient, further studies of short- and long-term toxicity are essential, including genotoxicity, carcinogenic potential and food-drug interactions [3]. Reported side effects across this literature are limited to mild injection site reactions. Nearly all of it comes from one research group in Russia [3][6].
Contraindications
- Pregnancy or planning to become pregnant
- Currently breastfeeding
- Active cancer or history of cancer
- Known allergy to peptide components
- Children and adolescents
Livagen
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Livagen (a liver-derived peptide extract) carries a safety profile established through decades of use in Eastern European hepatology and gastroenterology clinics. As an organ-derived extract rather than a synthetic single peptide, it contains multiple bioactive components promoting hepatocyte regeneration and cytoprotection. Adverse events are minimal in reported clinical experience—mild gastrointestinal upset occurring in <5% of patients. The compound shows no hepatotoxicity, nephrotoxicity, or immunosensitization in available safety surveillance data from thousands of patients.
Contraindications
- Known hypersensitivity to peptide bioregulators or constituent amino acids (lysine, glutamic acid, aspartic acid, alanine)
- Pregnancy and breastfeeding — insufficient reproductive safety data
- Active autoimmune conditions in flare without physician supervision
- Concurrent use of opioid medications — Livagen's enkephalinase inhibition may alter opioid metabolism
Decision guide
Which is right for you?
Epithalon
Choose Epithalon if…
- Longevity and healthy aging
- Cellular rejuvenation
- Sleep quality improvement
- Antioxidant support
Livagen
Choose Livagen if…
- Comprehensive geroprotective therapy targeting epigenetic chromatin remodeling in aging cells
- Supporting liver function and hepatoprotection in the context of aging
- Restoring protein synthesis and ribosomal function in elderly individuals
- Khavinson bioregulator protocols for anti-aging and longevity